177 related articles for article (PubMed ID: 20214524)
1. Neoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trials.
Sonpavde G; Palapattu GS
Expert Rev Anticancer Ther; 2010 Mar; 10(3):439-50. PubMed ID: 20214524
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
Sonpavde G; Chi KN; Powles T; Sweeney CJ; Hahn N; Hutson TE; Galsky MD; Berry WR; Kadmon D
Cancer; 2007 Dec; 110(12):2628-39. PubMed ID: 17941029
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant systemic therapy for urological malignancies.
Sonpavde G; Sternberg CN
BJU Int; 2010 Jul; 106(1):6-22. PubMed ID: 20553475
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant docetaxel treatment for locally advanced prostate cancer: a clinicopathologic study.
Magi-Galluzzi C; Zhou M; Reuther AM; Dreicer R; Klein EA
Cancer; 2007 Sep; 110(6):1248-54. PubMed ID: 17674353
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial.
Kim WY; Whang YE; Pruthi RS; Baggstrom MQ; Rathmell WK; Rosenman JG; Wallen EM; Goyal LK; Grigson G; Watkins C; Godley PA
Urol Oncol; 2011; 29(6):608-13. PubMed ID: 20022268
[TBL] [Abstract][Full Text] [Related]
6. A phase II clinical trial of neoadjuvant ketoconazole and docetaxel chemotherapy before radical prostatectomy in high risk patients.
Womble PR; VanVeldhuizen PJ; Nisbet AA; Reed GA; Thrasher JB; Holzbeierlein JM
J Urol; 2011 Sep; 186(3):882-7. PubMed ID: 21791342
[TBL] [Abstract][Full Text] [Related]
7. [Neoadjuvant androgen deprivation preceding to radical prostatectomy--its role in short-term and long-term outcomes].
Homma Y
Nihon Rinsho; 1998 Aug; 56(8):2162-6. PubMed ID: 9750527
[TBL] [Abstract][Full Text] [Related]
8. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemohormonal therapy in poor-prognosis localized prostate cancer.
Sella A; Zisman A; Kovel S; Yarom N; Leibovici D; Lindner A
Urology; 2008 Feb; 71(2):323-7. PubMed ID: 18308112
[TBL] [Abstract][Full Text] [Related]
10. Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer.
Chi KN; Chin JL; Winquist E; Klotz L; Saad F; Gleave ME
J Urol; 2008 Aug; 180(2):565-70; discussion 570. PubMed ID: 18554663
[TBL] [Abstract][Full Text] [Related]
11. Re: Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
Koontz BF; Moul J
Cancer; 2008 Jun; 112(11):2518-9; author reply 2519. PubMed ID: 18338760
[No Abstract] [Full Text] [Related]
12. Chemotherapy and novel therapeutics before radical prostatectomy for high-risk clinically localized prostate cancer.
Cha EK; Eastham JA
Urol Oncol; 2015 May; 33(5):217-25. PubMed ID: 25596644
[TBL] [Abstract][Full Text] [Related]
13. [Neoadjuvant therapy of prostate carcinoma].
Ebert T
Praxis (Bern 1994); 1997 Nov; 86(46):1815-8. PubMed ID: 9454282
[TBL] [Abstract][Full Text] [Related]
14. Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.
Wood DP; Beaman A; Banerjee M; Powell I; Pontes E; Cher ML
Clin Cancer Res; 1998 Sep; 4(9):2119-23. PubMed ID: 9748128
[TBL] [Abstract][Full Text] [Related]
15. [New development of endocrine therapy in prostate cancer].
Naito S
Gan To Kagaku Ryoho; 1996 May; 23(6):684-8. PubMed ID: 8645018
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints.
Oh WK
Urol Oncol; 2003; 21(3):229-34. PubMed ID: 12810211
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Chemotherapy Using Reduced-Dose Docetaxel Followed by Radical Prostatectomy for Patients With Intermediate and High-Risk Prostate Cancer: A Single-Center Study.
Nosov A; Reva S; Petrov S; Mamijev E; Novikov R; Veliev E; Imkamp F; Tolkach Y; Moiseenko V
Prostate; 2016 Nov; 76(15):1345-52. PubMed ID: 26864707
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer.
Febbo PG; Richie JP; George DJ; Loda M; Manola J; Shankar S; Barnes AS; Tempany C; Catalona W; Kantoff PW; Oh WK
Clin Cancer Res; 2005 Jul; 11(14):5233-40. PubMed ID: 16033841
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy for prostate cancer patients at high risk of recurrence following radical prostatectomy.
Andriole GL
Eur Urol; 1997; 32 Suppl 3():65-9. PubMed ID: 9267788
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant therapy prior to radiotherapy for clinically localized prostate cancer.
Roach M
Eur Urol; 1997; 32 Suppl 3():48-54. PubMed ID: 9267785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]